» Articles » PMID: 19414598

MiR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor Alpha MRNA

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2009 May 6
PMID 19414598
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Estrogen receptor alpha (ER alpha) is a ligand-regulated transcription factor with a broad range of physiological functions and one of the most important classifiers in breast cancer. MicroRNAs (miRNAs) are small noncoding RNAs that have emerged as important regulators of gene expression in a plethora of physiological and pathological processes. Upon binding the 3' untranslated region (UTR) of target mRNAs, miRNAs typically reduce their stability and/or translation. The ER alpha mRNA has a long 3' UTR of about 4.3 kb which has been reported to reduce mRNA stability and which bears evolutionarily conserved miRNA target sites, suggesting that it might be regulated by miRNAs. We have performed a comprehensive and systematic assessment of the regulatory role of all miRNAs that are predicted to target the 3' UTR of the ER alpha mRNA. We found that miR-22 represses ER alpha expression most strongly and by directly targeting the ER alpha mRNA 3' UTR. Of the three predicted miR-22 target sites in the 3' UTR, the evolutionarily conserved one is the primary target. miR-22 overexpression leads to a reduction of ER alpha levels, at least in part by inducing mRNA degradation, and compromises estrogen signaling, as exemplified by its inhibitory impact on the ER alpha-dependent proliferation of breast cancer cells.

Citing Articles

Therapeutic Targeting of the Galectin-1/miR-22-3p Axis Regulates Cell Cycle and EMT Depending on the Molecular Subtype of Breast Cancer.

Kim J, Lee J, Jung E, Son Y, Park H, Kim J Cells. 2025; 14(4).

PMID: 39996781 PMC: 11854374. DOI: 10.3390/cells14040310.


The Role of microRNA-22 in Metabolism.

Tomasini S, Vigo P, Margiotta F, Scheele U, Panella R, Kauppinen S Int J Mol Sci. 2025; 26(2).

PMID: 39859495 PMC: 11766054. DOI: 10.3390/ijms26020782.


Expression profiles of circulating miRNAs in an endangered Piedmontese sheep breed during the estrus cycle.

Manenti I, Ala U, Macchi E, Viola I, Toschi P, Accornero P Front Vet Sci. 2024; 11:1458463.

PMID: 39564184 PMC: 11575464. DOI: 10.3389/fvets.2024.1458463.


Advances in the study of the mechanism of action of miR‑22 in liver lesions (Review).

Wang M, Wang X, Wang Y, Gai Y, Ye J, Xu X Oncol Lett. 2024; 28(5):541.

PMID: 39310022 PMC: 11413475. DOI: 10.3892/ol.2024.14674.


The interplay of hydrogen sulfide and microRNAs in cardiovascular diseases: insights and future perspectives.

Song Y, Cao S, Sun X, Chen G Mamm Genome. 2024; 35(3):309-323.

PMID: 38834923 DOI: 10.1007/s00335-024-10043-6.


References
1.
Ibarra I, Erlich Y, Muthuswamy S, Sachidanandam R, Hannon G . A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev. 2007; 21(24):3238-43. PMC: 2113025. DOI: 10.1101/gad.1616307. View

2.
Griffiths-Jones S, Saini H, van Dongen S, Enright A . miRBase: tools for microRNA genomics. Nucleic Acids Res. 2007; 36(Database issue):D154-8. PMC: 2238936. DOI: 10.1093/nar/gkm952. View

3.
Mattie M, Benz C, Bowers J, Sensinger K, Wong L, Scott G . Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer. 2006; 5:24. PMC: 1563474. DOI: 10.1186/1476-4598-5-24. View

4.
Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N . Widespread changes in protein synthesis induced by microRNAs. Nature. 2008; 455(7209):58-63. DOI: 10.1038/nature07228. View

5.
Lewis B, Shih I, Jones-Rhoades M, Bartel D, Burge C . Prediction of mammalian microRNA targets. Cell. 2003; 115(7):787-98. DOI: 10.1016/s0092-8674(03)01018-3. View